Bottom Line: Beyond the Boots drug fiasco

IF COMPANY annual meetings were a serious forum for investors to question their management boards, then Boots' yearly jamboree on Thursday would provide an ample opportunity.

Less than seven weeks after Sir James Blyth, the chief executive, reassured all and sundry at the company's preliminary results that he was confident that regulators would approve continued use of Manoplax, its over-hyped heart decongestant drug, Boots has had to scrap it.

Not only will the bill for shareholders approach pounds 200m in wasted development costs of pounds 100m, futile marketing expenditure totalling pounds 20m to pounds 30m, a pounds 35m write-down of stock and manufacturing facilities and a likely pounds 10m to pounds 15m staff redundancy charge.

The Manoplax disaster also raises the vital question of the future of Boots' pharmaceutical division, which contributed pounds 121m out of 1992/3 operating profits of pounds 422m.

Synthroid, the thyroid replacement therapy, is a resilent enough off-patent drug, but there is nothing significant in the pipeline.

Minus Manoplax, Boots, if it wasn't already, is now a relatively negligible force in prescription pharmaceuticals, which produce perhaps 70 per cent of the division's earnings.

This points firmly to divestment of ethical drugs and reinvestment in over-the-counter products or an accelerated expansion into pan-European retailing. The problem is that Boots' ethical drug portfolio isn't worth much, which is affecting its share rating, and corresponding buying opportunities are expensive.

Some estimate that Boots could get pounds 400m to pounds 500m for the ethical drugs business. To replace perhaps pounds 80m of operating profits with the proceeds without diluting earnings is a tough proposition for a company that perpetrated Ward White.

Recognising that Boots is in a cleft stick, the stock market has put the boot firmly into its share price this year, causing it to underperform by 25 per cent. There has also been a stream of negative publicity about its successful core business, Boots the Chemist.

This has left Boots shares languishing on a p/e of 14.5 and 13 for the next two financial years respectively, adding back non-recurring Manoplax operating expenses, or a 2 or 3 point discount to its peers.

Despite a 13p flip-up in the shares to 435p, this rating gap will not be closed until Sir James Blyth and his team take a more comprehensive grip on pharmaceuticals and do something about Do It All - ghoulish reminder as it is of the disastrous Ward White acquisition - which is losing pounds 20m to pounds 30m a year.

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Ugne, 32, is a Lithuanian bodybuilder
tvThey include a Lithuanian bodybuilder who believes 'cake is a sin' and the Dalai Lama's personal photographer
Arts and Entertainment
Amazon have just launched their new streaming service in the UK
music
News
Donald Trump
people
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Research Associate / Asset Management Research Analyst

£40 - 45k (DOE) + Benefits: Guru Careers: A Research Associate / Research Anal...

The Green Recruitment Company: Graduate Energy Analyst

£20000 Per Annum: The Green Recruitment Company: Summary: The Green Recruitm...

Ashdown Group: Finance Accountant - Financial Services - Central London

£30000 - £35000 per annum + benefits : Ashdown Group: Finance Accountant - Fin...

Ashdown Group: Chief Technology Officer (CTO) - Glasgow

£90000 - £98000 per annum + benefits : Ashdown Group: A truly exciting opportu...

Day In a Page

Solved after 200 years: the mysterious deaths of 3,000 soldiers from Napoleon's army

Solved after 200 years

The mysterious deaths of 3,000 soldiers from Napoleon's army
Every regional power has betrayed the Kurds so Turkish bombing is no surprise

Robert Fisk on the Turkey conflict

Every regional power has betrayed the Kurds so Turkish bombing is no surprise
Investigation into wreck of unidentified submarine found off the coast of Sweden

Sunken sub

Investigation underway into wreck of an unidentified submarine found off the coast of Sweden
Instagram and Facebook have 'totally changed' the way people buy clothes

Age of the selfie

Instagram and Facebook have 'totally changed' the way people buy clothes
Not so square: How BBC's Bloomsbury saga is sexing up the period drama

Not so square

How Virginia Woolf saga is sexing up the BBC period drama
Rio Olympics 2016: The seven teenagers still carrying a torch for our Games hopes

Still carrying the torch

The seven teenagers given our Olympic hopes
The West likes to think that 'civilisation' will defeat Isis, but history suggests otherwise

The West likes to think that 'civilisation' will defeat Isis...

...but history suggests otherwise
The bald truth: How one author's thinning hair made him a Wayne Rooney sympathiser

The bald truth

How thinning hair made me a Wayne Rooney sympathiser
Froome wins second Tour de France after triumphant ride into Paris with Team Sky

Tour de France 2015

Froome rides into Paris to win historic second Tour
Fifteen years ago, Concorde crashed, and a dream died. Today, the desire to travel faster than the speed of sound is growing once again

A new beginning for supersonic flight?

Concorde's successors are in the works 15 years on from the Paris crash
I would never quit Labour, says Liz Kendall

I would never quit party, says Liz Kendall

Latest on the Labour leadership contest
Froome seals second Tour de France victory

Never mind Pinot, it’s bubbly for Froome

Second Tour de France victory all but sealed
Oh really? How the 'lowest form of wit' makes people brighter and more creative

The uses of sarcasm

'Lowest form of wit' actually makes people brighter and more creative
A magazine editor with no vanity, and lots of flair

No vanity, but lots of flair

A tribute to the magazine editor Ingrid Sischy
Foraging: How the British rediscovered their taste for chasing after wild food

In praise of foraging

How the British rediscovered their taste for wild food